PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
GERM vs. SBIO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between GERM and SBIO is 0.02, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

GERM vs. SBIO

Last updated Jun 1, 2025

Compare and contrast key facts about ETFMG Treatments Testing and Advancements ETF (GERM) and ALPS Medical Breakthroughs ETF (SBIO).

GERM and SBIO are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. GERM is a passively managed fund by ETFMG that tracks the performance of the Prime Treatments, Testing and Advancements Index. It was launched on Jun 17, 2020. SBIO is a passively managed fund by SS&C that tracks the performance of the S-Network Medical Breakthroughs Index. It was launched on Dec 31, 2014. Both GERM and SBIO are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GERM or SBIO.

Performance

GERM vs. SBIO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ETFMG Treatments Testing and Advancements ETF (GERM) and ALPS Medical Breakthroughs ETF (SBIO). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Returns By Period

GERM

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

3Y*

N/A

5Y*

N/A

10Y*

N/A

SBIO

YTD

-11.80%

1M

-1.72%

6M

-22.39%

1Y

-10.39%

3Y*

5.59%

5Y*

-6.14%

10Y*

-0.70%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

ETFMG Treatments Testing and Advancements ETF

ALPS Medical Breakthroughs ETF

GERM vs. SBIO - Expense Ratio Comparison

GERM has a 0.68% expense ratio, which is higher than SBIO's 0.50% expense ratio.

GERM
ETFMG Treatments Testing and Advancements ETF
SBIO
ALPS Medical Breakthroughs ETF
Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

GERM vs. SBIO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
GERM
The Risk-Adjusted Performance Rank of GERM is 77
Overall Rank
The Sharpe Ratio Rank of GERM is 44
Sharpe Ratio Rank
The Sortino Ratio Rank of GERM is 1212
Sortino Ratio Rank
The Omega Ratio Rank of GERM is 1515
Omega Ratio Rank
The Calmar Ratio Rank of GERM is 11
Calmar Ratio Rank
The Martin Ratio Rank of GERM is 55
Martin Ratio Rank
SBIO
The Risk-Adjusted Performance Rank of SBIO is 99
Overall Rank
The Sharpe Ratio Rank of SBIO is 77
Sharpe Ratio Rank
The Sortino Ratio Rank of SBIO is 1010
Sortino Ratio Rank
The Omega Ratio Rank of SBIO is 1010
Omega Ratio Rank
The Calmar Ratio Rank of SBIO is 1010
Calmar Ratio Rank
The Martin Ratio Rank of SBIO is 1010
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

GERM vs. SBIO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ETFMG Treatments Testing and Advancements ETF (GERM) and ALPS Medical Breakthroughs ETF (SBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

No data
No data
No data
No data
No data

Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

GERM vs. SBIO - Dividend Comparison

GERM has not paid dividends to shareholders, while SBIO's dividend yield for the trailing twelve months is around 4.03%.

TTM20242023202220212020201920182017
GERM
ETFMG Treatments Testing and Advancements ETF		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SBIO
ALPS Medical Breakthroughs ETF		4.03%3.55%0.22%0.00%0.00%0.00%0.04%2.79%1.77%

Drawdowns

GERM vs. SBIO - Drawdown Comparison

Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

GERM vs. SBIO - Volatility Comparison

Loading data...